SARS-CoV-2-free residual proteins mediated phenotypic and metabolic changes in peripheral blood monocytic-derived macrophages in support of viral pathogenesis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
27
10
2022
accepted:
03
01
2023
entrez:
19
1
2023
pubmed:
20
1
2023
medline:
24
1
2023
Statut:
epublish
Résumé
The large-scale dissemination of coronavirus disease-2019 (COVID-19) and its serious complications have pledged the scientific research communities to uncover the pathogenesis mechanisms of its etiologic agent, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Methods of unveiling such mechanisms are rooted in understanding the viral agent's interactions with the immune system, including its ability to activate macrophages, due to their suggested role in prolonged inflammatory phases and adverse immune responses. The objective of this study is to test the effect of SARS-CoV-2-free proteins on the metabolic and immune responses of macrophages. We hypothesized that SARS-CoV-2 proteins shed during the infection cycle may dynamically induce metabolic and immunologic alterations with an inflammatory impact on the infected host cells. It is imperative to delineate such alterations in the context of macrophages to gain insight into the pathogenesis of these highly infectious viruses and their associated complications and thus, expedite the vaccine and drug therapy advent in combat of viral infections. Human monocyte-derived macrophages were treated with SARS-CoV-2-free proteins at different concentrations. The phenotypic and metabolic alterations in macrophages were investigated and the subsequent metabolic pathways were analyzed. The obtained results indicated that SARS-CoV-2-free proteins induced concentration-dependent alterations in the metabolic and phenotypic profiles of macrophages. Several metabolic pathways were enriched following treatment, including vitamin K, propanoate, and the Warburg effect. These results indicate significant adverse effects driven by residual viral proteins that may hence be considered determinants of viral pathogenesis. These findings provide important insight as to the impact of SARS-CoV-2-free residual proteins on the host cells and suggest a potential new method of management during the infection and prior to vaccination.
Identifiants
pubmed: 36656874
doi: 10.1371/journal.pone.0280592
pii: PONE-D-22-29694
pmc: PMC9851515
doi:
Substances chimiques
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0280592Informations de copyright
Copyright: © 2023 Mohammad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
iScience. 2021 Jun 25;24(6):102681
pubmed: 34095780
Cell Res. 2017 Jan;27(1):119-129
pubmed: 28008928
Front Immunol. 2021 Sep 03;12:707267
pubmed: 34539639
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17253-8
pubmed: 24101477
Nat Commun. 2020 Oct 30;11(1):5493
pubmed: 33127906
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W652-60
pubmed: 19429898
mBio. 2019 Mar 12;10(2):
pubmed: 30862747
J Infect Dis. 2020 Aug 4;222(5):734-745
pubmed: 32563187
Cell Cycle. 2015;14(7):980-9
pubmed: 25602755
J Immunol. 2014 Dec 1;193(11):5595-603
pubmed: 25367121
Int J Mol Sci. 2018 Jun 19;19(6):
pubmed: 29921749
PLoS One. 2020 Oct 6;15(10):e0240156
pubmed: 33022008
Infection. 2021 Oct;49(5):855-876
pubmed: 34339040
J Immunol. 2016 Oct 1;197(7):2880-90
pubmed: 27566823
J Proteomics. 2015 Jun 21;124:112-23
pubmed: 25857278
Clin Infect Dis. 2020 Nov 5;71(8):1937-1942
pubmed: 32301997
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
Cell Metab. 2020 Sep 1;32(3):437-446.e5
pubmed: 32697943
Nat Protoc. 2011 Jun;6(6):743-60
pubmed: 21637195
Immun Ageing. 2020 Nov 9;17(1):33
pubmed: 33292333
Viruses. 2021 Nov 03;13(11):
pubmed: 34835015
Clin Chem. 2021 Dec 30;68(1):240-248
pubmed: 34358289
J Virol. 2021 Jan 28;95(4):
pubmed: 33208449
Front Immunol. 2020 Aug 26;11:2037
pubmed: 32983152
J Immunol. 1997 Dec 1;159(11):5474-82
pubmed: 9548487
Int J Mol Sci. 2021 Aug 22;22(16):
pubmed: 34445747
EBioMedicine. 2020 Apr;54:102734
pubmed: 32279057
Trends Mol Med. 2013 Apr;19(4):217-26
pubmed: 23375872
Sci Rep. 2019 Mar 8;9(1):3941
pubmed: 30850623
Nat Rev Immunol. 2011 Oct 14;11(11):723-37
pubmed: 21997792
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):42S-47S
pubmed: 30428703
Life Sci. 2021 Mar 15;269:119010
pubmed: 33454368
Front Microbiol. 2022 Mar 21;13:863133
pubmed: 35387075
Biochemistry (Mosc). 2021 Mar;86(3):257-261
pubmed: 33838638
Clin Transl Immunology. 2016 Apr 22;5(4):e73
pubmed: 27195116
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Nat Microbiol. 2021 Jul;6(7):899-909
pubmed: 33907312
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
Biochimie. 2021 Jan;180:169-177
pubmed: 33189832
J Int Med Res. 2022 Feb;50(2):3000605221082898
pubmed: 35226548
Scand J Clin Lab Invest. 2020 Nov;80(7):525-527
pubmed: 32779537
Cells. 2020 Dec 08;9(12):
pubmed: 33302501
Virology. 2015 May;479-480:609-18
pubmed: 25812764
Cell Death Differ. 2020 Dec;27(12):3209-3225
pubmed: 33037393
Biomark Res. 2021 Jan 6;9(1):1
pubmed: 33407885
Molecules. 2019 Jan 22;24(3):
pubmed: 30678308
Rev Med Virol. 2021 Sep;31(5):1-13
pubmed: 34546604
Metabolites. 2021 Jan 09;11(1):
pubmed: 33435351
Biochem J. 2020 Jul 17;477(13):2489-2507
pubmed: 32538426
Int J Mol Sci. 2021 Jul 14;22(14):
pubmed: 34299155
Natl Sci Rev. 2020 Jun;7(6):998-1002
pubmed: 34676125
Clin Infect Dis. 2021 Dec 6;73(11):e4039-e4046
pubmed: 32852539
Cell Host Microbe. 2021 Jul 14;29(7):1052-1062
pubmed: 34022154
Cell Discov. 2020 May 4;6:31
pubmed: 32377375
Cytokine. 2000 Nov;12(11):1639-46
pubmed: 11052814
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Rev Immunol. 2005 Dec;5(12):953-64
pubmed: 16322748
Nat Commun. 2021 Nov 15;12(1):6602
pubmed: 34782627
J Korean Med Sci. 2020 Sep 28;35(38):e343
pubmed: 32989935
Aliment Pharmacol Ther. 2018 Jul;48(1):15-34
pubmed: 29722430
Nat Biotechnol. 2009 Dec;27(12):1135-7
pubmed: 20010596
Curr Protoc Bioinformatics. 2011 Jun;Chapter 14:14.10.1-14.10.48
pubmed: 21633943
Cell Discov. 2020 Sep 15;6:65
pubmed: 32953130